SYRAVDA
LIVE

Serial Number

79260487

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SYRAVDA Trademark

Serial Number: 79260487 • Registration: 5887856

SYRAVDA is a trademark filed by Novartis AG on March 6, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

March 6, 2019

Registration Date

October 22, 2019

Published for Opposition

August 6, 2019

Cancellation Date

May 8, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CANCELLED SECTION 71
May 8, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 22, 2024 REM3
NOTIFICATION PROCESSED BY IB
Feb 14, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 14, 2019 FICS
FINAL DISPOSITION PROCESSED
Dec 14, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 21, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2019 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
PUBLISHED FOR OPPOSITION
Aug 6, 2019 PUBO
NOTICE OF PUBLICATION
Jul 17, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2019 CNSA
APPLICATION FILING RECEIPT MAILED
Jun 28, 2019 MAFR
ASSIGNED TO EXAMINER
Jun 24, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 17, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 6, 2019 SDRC